KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) Equity Ratio (2016 - 2025)

Teladoc Health (TDOC) has disclosed Equity Ratio for 12 consecutive years, with 0.48 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 14.33% to 0.48 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.48 through Dec 2025, up 14.33% year-over-year, with the annual reading at 0.48 for FY2025, 14.33% up from the prior year.
  • Equity Ratio hit 0.48 in Q4 2025 for Teladoc Health, roughly flat from 0.48 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.91 in Q2 2021 to a low of 0.41 in Q1 2025.
  • Historically, Equity Ratio has averaged 0.61 across 5 years, with a median of 0.53 in 2022.
  • Biggest five-year swings in Equity Ratio: skyrocketed 44.3% in 2021 and later crashed 41.3% in 2022.
  • Year by year, Equity Ratio stood at 0.9 in 2021, then plummeted by 41.3% to 0.53 in 2022, then decreased by 0.28% to 0.53 in 2023, then dropped by 19.93% to 0.42 in 2024, then grew by 14.33% to 0.48 in 2025.
  • Business Quant data shows Equity Ratio for TDOC at 0.48 in Q4 2025, 0.48 in Q3 2025, and 0.49 in Q2 2025.